Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pulmonary Hypertension in 2021: Part I—Definition, Classification, Pathophysiology, and Presentation
Theresa A. Gelzinis
Journal of Cardiothoracic and Vascular Anesthesia (2021) Vol. 36, Iss. 6, pp. 1552-1564
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies
Helen Christou, Raouf A. Khalil
AJP Heart and Circulatory Physiology (2022) Vol. 322, Iss. 5, pp. H702-H724
Open Access | Times Cited: 47
Molecular Pathways in Pulmonary Arterial Hypertension
Aangi J. Shah, Mounica Vorla, Dinesh Kalra
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10001-10001
Open Access | Times Cited: 37
Parameter inference in a computational model of haemodynamics in pulmonary hypertension
Amanda L. Colunga, Mitchel J. Colebank, Mette S. Olufsen
Journal of The Royal Society Interface (2023) Vol. 20, Iss. 200
Open Access | Times Cited: 17
MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment
Łukasz Wołowiec, Martyna Mędlewska, Joanna Osiak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9735-9735
Open Access | Times Cited: 13
Elevated Lp(a) and its association with cardiac fibrosis in group II pulmonary hypertension patients
Arif Albulushi, Shabib Al-Asmi, Moosa Al-Abri, et al.
Future Cardiology (2025), pp. 1-8
Closed Access
Fundamental and Targeted Approaches in Pulmonary Arterial Hypertension Treatment
Ji Su Park, Yong Hwan Choi, Ji-Young Min, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 224-224
Open Access
Insights into the relationship between serum uric acid and pulmonary hypertension (Review)
Yu Zhou, Meihong Chen, Jing Zheng, et al.
Molecular Medicine Reports (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Salt-inducible kinases: new players in pulmonary arterial hypertension?
Tatiana António, Patrício Soares‐da‐Silva, Nuno Pires, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 10, pp. 806-819
Closed Access | Times Cited: 13
The emerging role of NOTCH3 receptor signalling in human lung diseases
Manish Bodas, Subramaniyan Bharathiraja, Harry Karmouty‐Quintana, et al.
Expert Reviews in Molecular Medicine (2022) Vol. 24
Open Access | Times Cited: 12
‘Fear, uncertain, tired…...’ psychological distress among pulmonary hypertension patients: a qualitative interview study
Juxia Zhang, Yiyin Zhang, Yuhuan Yin, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Pulmonary Hypertension and the Risk of 30-Day Postoperative Pulmonary Complications after Gastrointestinal Surgical or Endoscopic Procedures: A Retrospective Propensity Score-Weighted Cohort Analysis
Yoshio Tatsuoka, Zyad J. Carr, Sachidhanand Jayakumar, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1996-1996
Open Access | Times Cited: 2
The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future
Jiuliang Zhao, Qian Wang, Xiaoyue Deng, et al.
Pharmacology & Therapeutics (2022) Vol. 239, pp. 108192-108192
Closed Access | Times Cited: 11
Electrocardiogram Parameters Associated With the Diagnosis of Pulmonary Hypertension in High-Altitude Tibetan Populations: A Retrospective Single-Centre Study
Ruimin Dong, Yu’en Liang, Ma Ni, et al.
Heart Lung and Circulation (2024) Vol. 33, Iss. 2, pp. 240-250
Closed Access | Times Cited: 1
Sinomenine Hydrochloride Regulates the Apoptosis of Endothelial Cells through PPAR-γ to Alleviate PAH
Weihua Chen, Xin Liu, Ziping Zhang, et al.
International Heart Journal (2024) Vol. 65, Iss. 5, pp. 929-938
Open Access | Times Cited: 1
Sex-Dependent Protective Effect of Combined Application of Solubilized Ubiquinol and Selenium on Monocrotaline-Induced Pulmonary Hypertension in Wistar Rats
Т. А. Куропаткина, O. S. Pavlova, М. V. Gulyaev, et al.
Antioxidants (2022) Vol. 11, Iss. 3, pp. 549-549
Open Access | Times Cited: 7
Monocrotaline-Induced Pulmonary Arterial Hypertension and Bosentan Treatment in Rats: Focus on Plasma and Erythrocyte Parameters
Tomáš Jasenovec, Dominika Radošinská, Marta Kollárová, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1227-1227
Open Access | Times Cited: 7
Translational potential of targeting Anoctamin-1-Encoded Calcium-Activated chloride channels in hypertension
Connor Jimenez, Matthew B. Hawn, Elizabeth J. Akin, et al.
Biochemical Pharmacology (2022) Vol. 206, pp. 115320-115320
Open Access | Times Cited: 7
Pathological Roles for Endothelial Colony-Forming Cells in Neonatal and Adult Lung Disease
Jason O. Robertson, Serpil C. Erzurum, Kewal Asosingh
American Journal of Respiratory Cell and Molecular Biology (2022) Vol. 68, Iss. 1, pp. 13-22
Open Access | Times Cited: 6
Relationships between sexual function, mental health, and quality of life of female patients with pulmonary arterial hypertension associated with congenital heart disease
Sisi Chen, Ting Luo, Lingzhi Huang, et al.
Pulmonary Circulation (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 6
Super‐massive transfusion during liver transplantation
Warangkana Lapisatepun, Christina Ma, Worakitti Lapisatepun, et al.
Transfusion (2023) Vol. 63, Iss. 9, pp. 1677-1684
Open Access | Times Cited: 3
A Brief Review on Gender Differences in Mexican-Mestizo Patients with Pulmonary Arterial Hypertension (PAH) at a Tertiary-Level Hospital
María-del-Pilar Barragan-Martinez, Guillermo Cueto‐Robledo, Ernesto Roldán-Valadéz, et al.
Current Problems in Cardiology (2022) Vol. 47, Iss. 9, pp. 101275-101275
Closed Access | Times Cited: 3
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Przemysław Krajewski, Monika Turczyńska, Joanna Gołębiewska, et al.
Retina (2022) Vol. 42, Iss. 12, pp. 2354-2360
Closed Access | Times Cited: 3
Portopulmonary hypertension: peculiarities of diagnosis and treatment
S. Chooklin, S.S. Chuklin, M.M. Posivnych, et al.
EMERGENCY MEDICINE (2024) Vol. 20, Iss. 3, pp. 146-158
Open Access
Embolia cerebral paradójica por foramen oval temporal, como complicación de tromboembolismo pulmonar masivo - Reporte de Caso
Rodrigo Flores-Palacios, Yéssica Paola Reynoso Rejas, Andrés Guillermo Gutiérrez Avila
ACTA MEDICA PERUANA (2024) Vol. 41, Iss. 1
Open Access
Integrative bioinformatics approach for identifying key genes and potential therapeutic targets in the concurrent manifestation of hypertrophic cardiomyopathy and pulmonary hypertension
Xi Zheng, Chenyang Zhang, Tao Yang, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 5, pp. 3152-3169
Open Access
Page 1 - Next Page

Scroll to top